Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 12:2021:6661162.
doi: 10.1155/2021/6661162. eCollection 2021.

CUB and Sushi Multiple Domains (CSMD1) Gene Polymorphisms and Susceptibilities to Idiopathic Parkinson's Disease in Northern Chinese Han Population: A Case-Control Study

Affiliations

CUB and Sushi Multiple Domains (CSMD1) Gene Polymorphisms and Susceptibilities to Idiopathic Parkinson's Disease in Northern Chinese Han Population: A Case-Control Study

Xinling Bai et al. Parkinsons Dis. .

Abstract

Evidence has shown that the CUB and Sushi Multiple Domains (CSMD1) gene is an inhibitor of the complement activation pathway and is also involved in central nervous system inflammation. Previous studies have revealed that the CSMD1 gene is related to familial Parkinson's disease. This study aimed to investigate the relationship between CSMD1 gene and susceptibility to Parkinson's disease in population of northern China. A case-control study was performed on 423 Parkinson's disease patients and 465 healthy controls matched for age and sex. DNA from enrolled subjects were extracted from the peripheral blood, and single nucleotide polymorphisms (SNPs) rs12681349 (C>T), rs10503253 (C>A), and rs1983474 (T>G) within CSMD1 gene were genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Genotype frequency of rs10503253 (CA versus CC : OR = 1.554, 95% CI = 1.169-2.066, p=0.002) and rs1983474 (GG versus TT : OR = 0.599, 95% CI = 0.401-0.895, p=0.012) was significantly different between PD cases and controls, but not for rs12681349. Comprehensive and subgroup analysis indicated that rs10503252 showed significant statistical differences in the dominant model (AA + CA versus CC : OR = 0.677, 95% CI = 0.517-0.886, p=0.004), late-onset cohort (CA versus CC : OR = 1.570, 95% CI = 1.159-2.126, p=0.004), and the female cohort (CA versus CC : OR = 0.687, 95% CI = 0.497-0.952, p=0.023), compared with the matched control group. The difference of recessive model of rs1983474 (GG versus TT + TG : OR = 1.837, 95% CI = 1.287-2.620, p=0.001) was significant in Parkinson's disease. According to the subgroup analysis, results indicated that late-onset cohort (GG versus TT : OR = 0.643, 95% CI = 0.420-0.985, p=0.042), male cohort (TG versus TT : OR = 2.160, 95% CI = 1.162-4.016, p=0.015), and female group (GG versus TT : OR = 0.418, 95% CI = 0.234-0.746, p=0.003) of rs1983474 were significantly associated with Parkinson's disease susceptibility. In both genotype and subgroup analysis, we failed to find any relationship between rs12681349 polymorphism and Parkinson's disease risk. Our results indicate that the rs10503253 and rs1983474 gene polymorphism may be associated with idiopathic Parkinson's disease susceptibility in Chinese population. Nevertheless, these conclusions need to be further verified by more studies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Polymorphism for rs12681349 (CC/CT/TT), rs10503253 (CC/CA/AA), and rs1983474 (GG/TG/TT) was genotyped by PCR-RFLP.
Figure 2
Figure 2
Analysis of linkage disequilibrium between case group and control group.
Figure 3
Figure 3
ROC for rs12681349 and rs10503253 in the diagnosis of Parkinson's disease were compared. ROC: receiver operating curve, p value based on z statistics. p > 0.05 was considered as significant. Curve toward upper left corner indicates better performance.

Similar articles

Cited by

References

    1. De Lau L. M., Breteler M. M. Epidemiology of Parkinson’s disease. The Lancet Neurology. 2006;5(6):525–535. doi: 10.1016/s1474-4422(06)70471-9. - DOI - PubMed
    1. Tysnes O.-B., Storstein A. Epidemiology of Parkinson’s disease. Journal of Neural Transmission. 2017;124(8):901–905. doi: 10.1007/s00702-017-1686-y. - DOI - PubMed
    1. Garcia-Ruiz P. J., Chaudhuri K. R., Martinez-Martin P. Non-motor symptoms of Parkinson’s disease a review…from the past. Journal of the Neurological Sciences. 2014;338(1-2):30–33. doi: 10.1016/j.jns.2014.01.002. - DOI - PubMed
    1. Pfeiffer R. F. Non-motor symptoms in Parkinson’s disease. Parkinsonism & Related Disorders. 2016;22(Suppl 1):S119–S122. doi: 10.1016/j.parkreldis.2015.09.004. - DOI - PubMed
    1. Haaxma C. A., Bloem B. R., Borm G. F., et al. Gender differences in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry. 2007;78(8):819–824. doi: 10.1136/jnnp.2006.103788. - DOI - PMC - PubMed

LinkOut - more resources